We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Melatonin Shown to Inhibit the Effects of Aging

By LabMedica International staff writers
Posted on 09 Jul 2009
Scientists have found that a treatment based on melatonin can delay the first signs of aging in a small mammal. More...


Known as the "time-keeping” hormone, melatonin is naturally secreted by the body during the night. It is, therefore, a sort of biologic signal for nightfall, allowing an organism to synchronize itself with the day/night rhythm.

At the Laboratoire Arago in Banyuls sur Mer (France), Dr. Elodie Magnanou and her coworkers examined the long-term effects of melatonin on the Greater White-toothed shrew (Crocidura russula), a small nocturnal insectivorous mammal. Under normal conditions, this animal shows the first signs of aging after reaching 12 months, chiefly through the loss of circadian rhythm in its activities. By continuously administering melatonin, starting a little before 12 months, the appearance of these first signs was delayed by at least three months, which is a substantial period in relation to the lifespan of this shrew. (The Greater White-toothed shrew has a lifespan of 12 to 18 months in the wild and up to 30 months in captivity. Captivity does not change the time at which signs of aging appear it simply lengthens life.)

Melatonin is now known to play several beneficial roles. These include being an antioxidant, an antidepressant, and helping to remediate sleep problems. The next step will be to understand the mode of action of the hormone on aging, so researchers can possibly foresee its use on humans.

The study's findings appeared in the journal PLoS One on June 15, 2009.

Related Links:

Laboratoire Arago in Banyuls sur Mer




Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.